Market News AIOpen the app

Adagene and City of Hope are starting a Phase 1 trial to test a new treatment for tough metastatic colorectal cancer.

TrialRead the original at globenewswire.com
Good for ADAG

Adagene's new Phase 1 study advances testing of muzastotug in a cancer combination, a positive step for its drug program. It is still an early test, with no patient benefit reported.

ADAG · Adagene Inc.

AI read · Good for ADAG

The AI's read

This gives Adagene a chance to test muzastotug in a new treatment combination and advance its cancer program. The study is just beginning, so it has not shown that the drugs shrink tumors or help patients.

Get alerts for ADAG

Follow Adagene Inc. (ADAG) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ADAG
Free on the App Store and Google Play, or on the web.